Active Pharma Ingredient and Forecast Market

List of Tables
Table 1. Key Players of Active Pharma Ingredient in Global Market
Table 2. Top Active Pharma Ingredient Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Active Pharma Ingredient Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Active Pharma Ingredient Revenue Share by Companies, 2018-2023
Table 5. Global Active Pharma Ingredient Sales by Companies, (K Pcs), 2018-2023
Table 6. Global Active Pharma Ingredient Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Active Pharma Ingredient Price (2018-2023) & (USD/Pcs)
Table 8. Global Manufacturers Active Pharma Ingredient Product Type
Table 9. List of Global Tier 1 Active Pharma Ingredient Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Active Pharma Ingredient Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Active Pharma Ingredient Revenue, (US$, Mn), 2022 & 2032
Table 12. By Type - Global Active Pharma Ingredient Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Active Pharma Ingredient Revenue (US$, Mn), 2024-2032
Table 14. By Type - Global Active Pharma Ingredient Sales (K Pcs), 2018-2023
Table 15. By Type - Global Active Pharma Ingredient Sales (K Pcs), 2024-2032
Table 16. By Application ? Global Active Pharma Ingredient Revenue, (US$, Mn), 2022 & 2032
Table 17. By Application - Global Active Pharma Ingredient Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Active Pharma Ingredient Revenue (US$, Mn), 2024-2032
Table 19. By Application - Global Active Pharma Ingredient Sales (K Pcs), 2018-2023
Table 20. By Application - Global Active Pharma Ingredient Sales (K Pcs), 2024-2032
Table 21. By Region ? Global Active Pharma Ingredient Revenue, (US$, Mn), 2022 VS 2032
Table 22. By Region - Global Active Pharma Ingredient Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Active Pharma Ingredient Revenue (US$, Mn), 2024-2032
Table 24. By Region - Global Active Pharma Ingredient Sales (K Pcs), 2018-2023
Table 25. By Region - Global Active Pharma Ingredient Sales (K Pcs), 2024-2032
Table 26. By Country - North America Active Pharma Ingredient Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Active Pharma Ingredient Revenue, (US$, Mn), 2024-2032
Table 28. By Country - North America Active Pharma Ingredient Sales, (K Pcs), 2018-2023
Table 29. By Country - North America Active Pharma Ingredient Sales, (K Pcs), 2024-2032
Table 30. By Country - Europe Active Pharma Ingredient Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Active Pharma Ingredient Revenue, (US$, Mn), 2024-2032
Table 32. By Country - Europe Active Pharma Ingredient Sales, (K Pcs), 2018-2023
Table 33. By Country - Europe Active Pharma Ingredient Sales, (K Pcs), 2024-2032
Table 34. By Region - Asia Active Pharma Ingredient Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Active Pharma Ingredient Revenue, (US$, Mn), 2024-2032
Table 36. By Region - Asia Active Pharma Ingredient Sales, (K Pcs), 2018-2023
Table 37. By Region - Asia Active Pharma Ingredient Sales, (K Pcs), 2024-2032
Table 38. By Country - South America Active Pharma Ingredient Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Active Pharma Ingredient Revenue, (US$, Mn), 2024-2032
Table 40. By Country - South America Active Pharma Ingredient Sales, (K Pcs), 2018-2023
Table 41. By Country - South America Active Pharma Ingredient Sales, (K Pcs), 2024-2032
Table 42. By Country - Middle East & Africa Active Pharma Ingredient Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Active Pharma Ingredient Revenue, (US$, Mn), 2024-2032
Table 44. By Country - Middle East & Africa Active Pharma Ingredient Sales, (K Pcs), 2018-2023
Table 45. By Country - Middle East & Africa Active Pharma Ingredient Sales, (K Pcs), 2024-2032
Table 46. Teva Company Summary
Table 47. Teva Active Pharma Ingredient Product Offerings
Table 48. Teva Active Pharma Ingredient Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 49. Teva Key News & Latest Developments
Table 50. Novartis Company Summary
Table 51. Novartis Active Pharma Ingredient Product Offerings
Table 52. Novartis Active Pharma Ingredient Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 53. Novartis Key News & Latest Developments
Table 54. Pfizer Company Summary
Table 55. Pfizer Active Pharma Ingredient Product Offerings
Table 56. Pfizer Active Pharma Ingredient Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 57. Pfizer Key News & Latest Developments
Table 58. Johnson & Johnson Company Summary
Table 59. Johnson & Johnson Active Pharma Ingredient Product Offerings
Table 60. Johnson & Johnson Active Pharma Ingredient Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 61. Johnson & Johnson Key News & Latest Developments
Table 62. Mylan Company Summary
Table 63. Mylan Active Pharma Ingredient Product Offerings
Table 64. Mylan Active Pharma Ingredient Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 65. Mylan Key News & Latest Developments
Table 66. North China Pharmaceutical Group Company Summary
Table 67. North China Pharmaceutical Group Active Pharma Ingredient Product Offerings
Table 68. North China Pharmaceutical Group Active Pharma Ingredient Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 69. North China Pharmaceutical Group Key News & Latest Developments
Table 70. Dr. Reddy?s Laboratories Company Summary
Table 71. Dr. Reddy?s Laboratories Active Pharma Ingredient Product Offerings
Table 72. Dr. Reddy?s Laboratories Active Pharma Ingredient Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 73. Dr. Reddy?s Laboratories Key News & Latest Developments
Table 74. Roche Company Summary
Table 75. Roche Active Pharma Ingredient Product Offerings
Table 76. Roche Active Pharma Ingredient Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 77. Roche Key News & Latest Developments
Table 78. Aurobindo pharma Company Summary
Table 79. Aurobindo pharma Active Pharma Ingredient Product Offerings
Table 80. Aurobindo pharma Active Pharma Ingredient Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 81. Aurobindo pharma Key News & Latest Developments
Table 82. Sun Pharmaceutical Industries Company Summary
Table 83. Sun Pharmaceutical Industries Active Pharma Ingredient Product Offerings
Table 84. Sun Pharmaceutical Industries Active Pharma Ingredient Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 85. Sun Pharmaceutical Industries Key News & Latest Developments
Table 86. Boehringer Ingelheim GmbH Company Summary
Table 87. Boehringer Ingelheim GmbH Active Pharma Ingredient Product Offerings
Table 88. Boehringer Ingelheim GmbH Active Pharma Ingredient Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 89. Boehringer Ingelheim GmbH Key News & Latest Developments
Table 90. Bayer Company Summary
Table 91. Bayer Active Pharma Ingredient Product Offerings
Table 92. Bayer Active Pharma Ingredient Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 93. Bayer Key News & Latest Developments
Table 94. BASF Company Summary
Table 95. BASF Active Pharma Ingredient Product Offerings
Table 96. BASF Active Pharma Ingredient Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 97. BASF Key News & Latest Developments
Table 98. DSM Company Summary
Table 99. DSM Active Pharma Ingredient Product Offerings
Table 100. DSM Active Pharma Ingredient Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 101. DSM Key News & Latest Developments
Table 102. Zhejiang Medicine Company Summary
Table 103. Zhejiang Medicine Active Pharma Ingredient Product Offerings
Table 104. Zhejiang Medicine Active Pharma Ingredient Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 105. Zhejiang Medicine Key News & Latest Developments
Table 106. Biocon Company Summary
Table 107. Biocon Active Pharma Ingredient Product Offerings
Table 108. Biocon Active Pharma Ingredient Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 109. Biocon Key News & Latest Developments
Table 110. Johnson Matthey Company Summary
Table 111. Johnson Matthey Active Pharma Ingredient Product Offerings
Table 112. Johnson Matthey Active Pharma Ingredient Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 113. Johnson Matthey Key News & Latest Developments
Table 114. Hisun Pharmacy Company Summary
Table 115. Hisun Pharmacy Active Pharma Ingredient Product Offerings
Table 116. Hisun Pharmacy Active Pharma Ingredient Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 117. Hisun Pharmacy Key News & Latest Developments
Table 118. Cambrex Company Summary
Table 119. Cambrex Active Pharma Ingredient Product Offerings
Table 120. Cambrex Active Pharma Ingredient Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 121. Cambrex Key News & Latest Developments
Table 122. Shandong Xinhua Pharmaceutical Company Summary
Table 123. Shandong Xinhua Pharmaceutical Active Pharma Ingredient Product Offerings
Table 124. Shandong Xinhua Pharmaceutical Active Pharma Ingredient Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 125. Shandong Xinhua Pharmaceutical Key News & Latest Developments
Table 126. Lonza group Company Summary
Table 127. Lonza group Active Pharma Ingredient Product Offerings
Table 128. Lonza group Active Pharma Ingredient Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 129. Lonza group Key News & Latest Developments
Table 130. Huahai Pharmaceutical Company Summary
Table 131. Huahai Pharmaceutical Active Pharma Ingredient Product Offerings
Table 132. Huahai Pharmaceutical Active Pharma Ingredient Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 133. Huahai Pharmaceutical Key News & Latest Developments
Table 134. Haerbin Pharmaceutical Group Company Summary
Table 135. Haerbin Pharmaceutical Group Active Pharma Ingredient Product Offerings
Table 136. Haerbin Pharmaceutical Group Active Pharma Ingredient Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 137. Haerbin Pharmaceutical Group Key News & Latest Developments
Table 138. Cipla Company Summary
Table 139. Cipla Active Pharma Ingredient Product Offerings
Table 140. Cipla Active Pharma Ingredient Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 141. Cipla Key News & Latest Developments
Table 142. Tian Yao Company Summary
Table 143. Tian Yao Active Pharma Ingredient Product Offerings
Table 144. Tian Yao Active Pharma Ingredient Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 145. Tian Yao Key News & Latest Developments
Table 146. Lupin Company Summary
Table 147. Lupin Active Pharma Ingredient Product Offerings
Table 148. Lupin Active Pharma Ingredient Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 149. Lupin Key News & Latest Developments
Table 150. North East Pharmaceutical Company Summary
Table 151. North East Pharmaceutical Active Pharma Ingredient Product Offerings
Table 152. North East Pharmaceutical Active Pharma Ingredient Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 153. North East Pharmaceutical Key News & Latest Developments
Table 154. Albemarle Company Summary
Table 155. Albemarle Active Pharma Ingredient Product Offerings
Table 156. Albemarle Active Pharma Ingredient Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 157. Albemarle Key News & Latest Developments
Table 158. Shandong Lukang Pharmaceutical Company Summary
Table 159. Shandong Lukang Pharmaceutical Active Pharma Ingredient Product Offerings
Table 160. Shandong Lukang Pharmaceutical Active Pharma Ingredient Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 161. Shandong Lukang Pharmaceutical Key News & Latest Developments
Table 162. Jiangsu Hengrui Medicine Company Summary
Table 163. Jiangsu Hengrui Medicine Active Pharma Ingredient Product Offerings
Table 164. Jiangsu Hengrui Medicine Active Pharma Ingredient Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 165. Jiangsu Hengrui Medicine Key News & Latest Developments
Table 166. Active Pharma Ingredient Production Capacity (K Pcs) of Key Manufacturers in Global Market, 2021-2023 (K Pcs)
Table 167. Global Active Pharma Ingredient Capacity Market Share of Key Manufacturers, 2021-2023
Table 168. Global Active Pharma Ingredient Production by Region, 2018-2023 (K Pcs)
Table 169. Global Active Pharma Ingredient Production by Region, 2024-2032 (K Pcs)
Table 170. Active Pharma Ingredient Market Opportunities & Trends in Global Market
Table 171. Active Pharma Ingredient Market Drivers in Global Market
Table 172. Active Pharma Ingredient Market Restraints in Global Market
Table 173. Active Pharma Ingredient Raw Materials
Table 174. Active Pharma Ingredient Raw Materials Suppliers in Global Market
Table 175. Typical Active Pharma Ingredient Downstream
Table 176. Active Pharma Ingredient Downstream Clients in Global Market
Table 177. Active Pharma Ingredient Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Active Pharma Ingredient Segment by Type in 2022
Figure 2. Active Pharma Ingredient Segment by Application in 2022
Figure 3. Global Active Pharma Ingredient Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Active Pharma Ingredient Market Size: 2022 VS 2032 (US$, Mn)
Figure 6. Global Active Pharma Ingredient Revenue, 2018-2032 (US$, Mn)
Figure 7. Active Pharma Ingredient Sales in Global Market: 2018-2032 (K Pcs)
Figure 8. The Top 3 and 5 Players Market Share by Active Pharma Ingredient Revenue in 2022
Figure 9. By Type - Global Active Pharma Ingredient Revenue, (US$, Mn), 2022 & 2032
Figure 10. By Type - Global Active Pharma Ingredient Revenue Market Share, 2018-2032
Figure 11. By Type - Global Active Pharma Ingredient Sales Market Share, 2018-2032
Figure 12. By Type - Global Active Pharma Ingredient Price (USD/Pcs), 2018-2032
Figure 13. By Application - Global Active Pharma Ingredient Revenue, (US$, Mn), 2022 & 2032
Figure 14. By Application - Global Active Pharma Ingredient Revenue Market Share, 2018-2032
Figure 15. By Application - Global Active Pharma Ingredient Sales Market Share, 2018-2032
Figure 16. By Application - Global Active Pharma Ingredient Price (USD/Pcs), 2018-2032
Figure 17. By Region - Global Active Pharma Ingredient Revenue, (US$, Mn), 2022 & 2032
Figure 18. By Region - Global Active Pharma Ingredient Revenue Market Share, 2018 VS 2022 VS 2032
Figure 19. By Region - Global Active Pharma Ingredient Revenue Market Share, 2018-2032
Figure 20. By Region - Global Active Pharma Ingredient Sales Market Share, 2018-2032
Figure 21. By Country - North America Active Pharma Ingredient Revenue Market Share, 2018-2032
Figure 22. By Country - North America Active Pharma Ingredient Sales Market Share, 2018-2032
Figure 23. US Active Pharma Ingredient Revenue, (US$, Mn), 2018-2032
Figure 24. Canada Active Pharma Ingredient Revenue, (US$, Mn), 2018-2032
Figure 25. Mexico Active Pharma Ingredient Revenue, (US$, Mn), 2018-2032
Figure 26. By Country - Europe Active Pharma Ingredient Revenue Market Share, 2018-2032
Figure 27. By Country - Europe Active Pharma Ingredient Sales Market Share, 2018-2032
Figure 28. Germany Active Pharma Ingredient Revenue, (US$, Mn), 2018-2032
Figure 29. France Active Pharma Ingredient Revenue, (US$, Mn), 2018-2032
Figure 30. U.K. Active Pharma Ingredient Revenue, (US$, Mn), 2018-2032
Figure 31. Italy Active Pharma Ingredient Revenue, (US$, Mn), 2018-2032
Figure 32. Russia Active Pharma Ingredient Revenue, (US$, Mn), 2018-2032
Figure 33. Nordic Countries Active Pharma Ingredient Revenue, (US$, Mn), 2018-2032
Figure 34. Benelux Active Pharma Ingredient Revenue, (US$, Mn), 2018-2032
Figure 35. By Region - Asia Active Pharma Ingredient Revenue Market Share, 2018-2032
Figure 36. By Region - Asia Active Pharma Ingredient Sales Market Share, 2018-2032
Figure 37. China Active Pharma Ingredient Revenue, (US$, Mn), 2018-2032
Figure 38. Japan Active Pharma Ingredient Revenue, (US$, Mn), 2018-2032
Figure 39. South Korea Active Pharma Ingredient Revenue, (US$, Mn), 2018-2032
Figure 40. Southeast Asia Active Pharma Ingredient Revenue, (US$, Mn), 2018-2032
Figure 41. India Active Pharma Ingredient Revenue, (US$, Mn), 2018-2032
Figure 42. By Country - South America Active Pharma Ingredient Revenue Market Share, 2018-2032
Figure 43. By Country - South America Active Pharma Ingredient Sales Market Share, 2018-2032
Figure 44. Brazil Active Pharma Ingredient Revenue, (US$, Mn), 2018-2032
Figure 45. Argentina Active Pharma Ingredient Revenue, (US$, Mn), 2018-2032
Figure 46. By Country - Middle East & Africa Active Pharma Ingredient Revenue Market Share, 2018-2032
Figure 47. By Country - Middle East & Africa Active Pharma Ingredient Sales Market Share, 2018-2032
Figure 48. Turkey Active Pharma Ingredient Revenue, (US$, Mn), 2018-2032
Figure 49. Israel Active Pharma Ingredient Revenue, (US$, Mn), 2018-2032
Figure 50. Saudi Arabia Active Pharma Ingredient Revenue, (US$, Mn), 2018-2032
Figure 51. UAE Active Pharma Ingredient Revenue, (US$, Mn), 2018-2032
Figure 52. Global Active Pharma Ingredient Production Capacity (K Pcs), 2018-2032
Figure 53. The Percentage of Production Active Pharma Ingredient by Region, 2022 VS 2032
Figure 54. Active Pharma Ingredient Industry Value Chain
Figure 55. Marketing Channels